Dermata Therapeutics Q3 EPS $(0.55), Inline
Benzinga Newsdesk 1 hour ago
NewsEarnings
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the same period last
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the same period last year.